BELLEVUE, Wash., June 10, 2014 (GLOBE NEWSWIRE) -- VitaCig, Inc., an mCig, Inc. (OTCQB:MCIG) Company, is pleased to provide results of the recently completed independent testing on its products. As previously announced in May, VitaCig implemented new production and chain of custody standards that included the independent testing of batches for the purpose of labeling each package with supplemental nutritional information, expiration dates, and traceable batch numbers.
In early May, VitaCig liquid batches were sent to an independent lab operated by Intertek Global, PLC. These batches were first tested for lead, arsenic, and any other potentially hazardous materials. Next, each batch was tested for vitamin and nutrient contents. Finally, the VitaCig and mCig stainless steel cylinders were also tested for hazardous materials or contaminants.
Results
On June 3, 2014, the company received the results of the independent testing:
-
All VitaCig batches tested were cleared of any hazardous substances in accordance with international standards.
-
VitaCig and mCig stainless steel cylinders were also cleared of hazardous materials.
- Vitamin and Phytonutrient contents were independently confirmed in the quantities that were intended in each batch.
The company is extremely satisfied with these results. mCig and VitaCig products already carry the coveted CE marking and are produced at RoHS certified facilities. With these results, the company is raising the bar yet again by attaching nutritional labeling in line with best industry practices for the nutritional supplements industry making the VitaCig - the only nicotine-free electronic cigarette (eCig) on the market with an independently tested nutritional label.
The company has already revised the VitaCig packaging to include these nutritional labels. To view the new nutritional label graphics for the VitaCig Relax, Refresh, and Energize visit: http://www.vitacig.org/discover/
Price Increase to $3 Each
On June 10, 2014, VitaCig prices will be raised to $3 each from $2 each as part of multiple retail distribution strategies being implemented that require a uniform retail MSRP for the product.
"We have decided to raise the price of VitaCig to $3. This decision was not driven by a rise in costs. In fact, the entire price increase will translate into additional profit for sales generated via our online store. This decision is driven by our recently implemented retail distribution strategy which relies on fixed embedded margins for each segment of the distribution channel. For VitaCig to succeed in retail storefronts, its cost to a consumer at point of sale must be comparable to that of a consumer purchasing direct from the company."
"We are very excited about the future of VitaCig, a product that has achieved growth at a more rapid pace than our game-changing mCig device. The mCig was purpose built for repeat use while the VitaCig is disposable leading to a higher percentage of repeat customers. In just 55 days of sales, 15% of all VitaCig customers have already re-ordered. Coupled with the nutritional labeling announced today, potential distributors can feel confident that this product has economic potential, chain of custody standards, and accountability of ingredients," said Paul Rosenberg, CEO of mCig, Inc.
About mCig, Inc.
mCig, Inc. (OTCQB:MCIG) is a technology company focused on two long-term secular trends sweeping the globe: (1) The decriminalization and legalization of marijuana for medicinal or recreational purposes (2) The adoption of electronic vaporizing cigarettes (commonly known as "eCigs") by the world's 1.2 Billion smokers. The company manufactures and retails the mCig – the world's most affordable vaporizer priced at only $10. Designed in the USA – the mCig provides a superior smoking experience by heating plant material, waxes, and oils delivering a smoother inhalation experience. The company also owns Vapolution, Inc. which manufactures and retails home-use vaporizers such as the Vapolution 2.0. Through its wholly owned subsidiary, VitaCig, Inc. the company manufactures and retails the VitaCig, a $3 nicotine-free eCig that delivers a water-vapor mixed with vitamins and organic flavors. Through its wholly owned subsidiary, LiqCig, Inc., the company is engaged in the development of the world's first pre-packaged alcohol friendly eCig. See more at: http://www.mCig.org/, www.Vapolution.com, www.VitaCig.org.
The Company believes that a well regulated marijuana industry is emerging as more states follow the lead of Washington and Colorado in legalizing marijuana. A similar trend is developing within the eCig industry following the first acquisition of an electronic cigarette brand (Blucigs) by a traditional tobacco company Lorillard Inc. for $135 million followed by another acquisition in February 2014 by Altria Group Inc. of Green Smoke for $150 million. Wells Fargo analyst Bonnie Herzog estimates that eCig sales may rise from $1 Billion in 2013 to $10 billion over the next three years.
mCig, Inc. (OTCQB:MCIG) has positioned itself as a first mover at the intersection of these two trends and hopes to create shareholder value by making the mCig one of the leading choices for electronic consumption of plant material. - See more at: http://www.mcig.org/investors/investor-opportunity-subpage/
Safe Harbor Statement
Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. Any forward-looking statements contained herein are based on current expectations, but are subject to a number of risks and uncertainties. The factors that could cause actual future results to differ materially from current expectations include, but are not limited to, risks and uncertainties relating to the Company's ability to develop, market and sell products based on its technology; the expected benefits and efficacy of the Company's products and technology; the availability of substantial additional funding for the Company to continue its operations and to conduct research and development, and future product commercialization; and the Company's business, research, product development, regulatory approval, marketing and distribution plans and strategies.